60 phenotypes from 2 alleles in 6 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Trpv1tm1Jbd/Trpv1tm1Jbd involves: 129P2/OlaHsd	abnormal sensory neuron physiology	J:161343
Trpv1tm1Jbd/Trpv1tm1Jbd involves: 129P2/OlaHsd * C57BL/6J	abnormal nervous system electrophysiology	J:62074
	abnormal nociception after inflammation	J:62074
	abnormal thermal nociception	J:62074
Trpv1tm1Jul/Trpv1tm1Jul B6.129X1-Trpv1tm1Jul	abnormal behavior	J:117778
	abnormal chemokine secretion	J:154624
	abnormal renal tubule morphology	J:154624
	abnormal urine homeostasis	J:154624
	normal behavior/neurological phenotype	J:117778
	decreased anxiety-related response	J:117778
	glomerulosclerosis	J:154624
	impaired contextual conditioning behavior	J:117778
	impaired cued conditioning behavior	J:117778
	increased interleukin-6 secretion	J:154624
	increased susceptibility to injury	J:154624
	increased tumor necrosis factor secretion	J:154624
	increased urine protein level	J:154624
	kidney inflammation	J:154624
	normal nervous system phenotype	J:117778
	reduced long-term potentiation	J:117778
Trpv1tm1Jul/Trpv1tm1Jul B6.129X1-Trpv1tm1Jul/J	abnormal action potential	J:109767
	abnormal hair cycle	J:110694
	abnormal hair cycle catagen phase	J:110694
	abnormal hair cycle telogen phase	J:110694
	abnormal mechanical nociception	J:128319
	abnormal nervous system electrophysiology	J:105254
	abnormal neuronal precursor proliferation	J:102006
	abnormal physiological response to xenobiotic	J:96901, J:105525, J:128319, J:132936
	abnormal response of heart to induced stress	J:116905
	abnormal righting response	J:153529
	abnormal taste sensitivity	J:145940
	alcohol preference	J:153529
	normal behavior/neurological phenotype	J:132700, J:153529
	decreased left ventricle diastolic pressure	J:116905
	decreased synaptic depression	J:132936
	impaired ability to fire action potentials	J:109767
	impaired behavioral response to alcohol	J:153529
	impaired coordination	J:153529
	increased alcohol consumption	J:153529
	increased blood osmolality	J:105254
	increased body weight	J:133914
	increased coronary flow rate	J:116905
	increased left ventricle developed pressure	J:116905
	increased thermal nociceptive threshold	J:96901
	reduced long-term depression	J:132936
Trpv1tm1Jul/Trpv1tm1Jul involves: 129X1/SvJ	abnormal nervous system electrophysiology	J:112194
	abnormal nociception after inflammation	J:61534
	abnormal sensory neuron physiology	J:61534
	decreased abdominal fat pad weight	J:137026
	decreased fat cell size	J:137026
	decreased fluid intake	J:112194
	decreased subcutaneous adipose tissue amount	J:137026
	decreased susceptibility to diet-induced hepatic steatosis	J:137026
	decreased susceptibility to diet-induced obesity	J:137026
	decreased susceptibility to induced hypothermia	J:137026
	hypoalgesia	J:61534, J:197482
	impaired ability to fire action potentials	J:112194
	increased chemical nociceptive threshold	J:61534
	increased thermal nociceptive threshold	J:61534, J:197482
Trpv1tm1Jul/Trpv1tm1Jul involves: 129X1/SvJ * C57BL/6	abnormal urination	J:78707
	decreased susceptibility to endotoxin shock	J:104828
	normal homeostasis/metabolism phenotype	J:104828
	impaired febrile response	J:104828
	increased incidence of tumors by chemical induction	J:144978
Gt(ROSA)26Sor/Gt(ROSA)26Sor+ Not Specified	abnormal body temperature	J:132700
	abnormal chemical nociception	J:132700
	abnormal pain threshold	J:132700
	abnormal physiological response to xenobiotic	J:132700
	increased thermal nociceptive threshold	J:132700